Graded association of muscle strength with all-cause and cause-specific mortality in older adults with diabetes: Prospective cohort study across 28 countries.

IF 5.4 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Lars Louis Andersen, Joaquín Calatayud, Rodrigo Núñez-Cortés, Ana Polo-López, Rubén López-Bueno
{"title":"Graded association of muscle strength with all-cause and cause-specific mortality in older adults with diabetes: Prospective cohort study across 28 countries.","authors":"Lars Louis Andersen, Joaquín Calatayud, Rodrigo Núñez-Cortés, Ana Polo-López, Rubén López-Bueno","doi":"10.1111/dom.16019","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The worldwide prevalence of diabetes is increasing, particularly among older adults. Understanding the association between muscle strength and mortality in this population is crucial for developing targeted exercise recommendations.</p><p><strong>Objectives: </strong>To assess the prospective association of muscle strength with mortality in older adults with diabetes.</p><p><strong>Methods: </strong>From the Survey of Health, Ageing and Retirement in Europe (SHARE) study, spanning 28 countries, we included 16 149 diabetic adults aged 50 years and older (mean age 68.2 [standard deviation, SD, 9.2] years). Participants fulfilled two criteria: (1) diabetes diagnosis (ever) and (2) current use of diabetes medication. Muscle strength was assessed using handgrip dynamometry (unit: kg). Using time-varying Cox regression with restricted cubic splines, we determined the prospective association of muscle strength with all-cause and cause-specific mortality, controlling for various confounders.</p><p><strong>Results: </strong>Over a mean follow-up of 5.9 years (SD 3.8), 2754 participants died (17%). Using the median level of muscle strength as reference (30 kg), lower and higher levels were associated in a curvilinear fashion with higher and lower all-cause mortality risk, respectively. The 10th percentile of muscle strength (17 kg) showed a hazard ratio (HR) of 1.65 (95% confidence interval (CI) 1.53-1.79). The 90th percentile (47 kg) of muscle strength showed a HR of 0.55 (95% CI 0.49-0.63). A somewhat similar pattern, with varying strength of associations, was seen for mortality due to cardiovascular disease (CVD), respiratory disease, severe infectious disease, digestive system disease and cancer.</p><p><strong>Conclusion: </strong>Muscle strength is gradually and inversely associated with all-cause and cause-specific mortality risk in older adults with diabetes. As muscle strength is highly adaptable to resistance training at all ages, the present findings highlight the importance of improving muscle strength in older adults with diabetes.</p>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":" ","pages":""},"PeriodicalIF":5.4000,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Obesity & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/dom.16019","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The worldwide prevalence of diabetes is increasing, particularly among older adults. Understanding the association between muscle strength and mortality in this population is crucial for developing targeted exercise recommendations.

Objectives: To assess the prospective association of muscle strength with mortality in older adults with diabetes.

Methods: From the Survey of Health, Ageing and Retirement in Europe (SHARE) study, spanning 28 countries, we included 16 149 diabetic adults aged 50 years and older (mean age 68.2 [standard deviation, SD, 9.2] years). Participants fulfilled two criteria: (1) diabetes diagnosis (ever) and (2) current use of diabetes medication. Muscle strength was assessed using handgrip dynamometry (unit: kg). Using time-varying Cox regression with restricted cubic splines, we determined the prospective association of muscle strength with all-cause and cause-specific mortality, controlling for various confounders.

Results: Over a mean follow-up of 5.9 years (SD 3.8), 2754 participants died (17%). Using the median level of muscle strength as reference (30 kg), lower and higher levels were associated in a curvilinear fashion with higher and lower all-cause mortality risk, respectively. The 10th percentile of muscle strength (17 kg) showed a hazard ratio (HR) of 1.65 (95% confidence interval (CI) 1.53-1.79). The 90th percentile (47 kg) of muscle strength showed a HR of 0.55 (95% CI 0.49-0.63). A somewhat similar pattern, with varying strength of associations, was seen for mortality due to cardiovascular disease (CVD), respiratory disease, severe infectious disease, digestive system disease and cancer.

Conclusion: Muscle strength is gradually and inversely associated with all-cause and cause-specific mortality risk in older adults with diabetes. As muscle strength is highly adaptable to resistance training at all ages, the present findings highlight the importance of improving muscle strength in older adults with diabetes.

糖尿病老年人肌肉力量与全因和特定原因死亡率的分级关系:横跨 28 个国家的前瞻性队列研究。
背景:全球糖尿病发病率正在上升,尤其是在老年人中。了解这一人群中肌肉力量与死亡率之间的关系对于制定有针对性的运动建议至关重要:评估患有糖尿病的老年人肌肉力量与死亡率之间的前瞻性联系:从横跨 28 个国家的欧洲健康、老龄化和退休调查(SHARE)研究中,我们纳入了 16 149 名 50 岁及以上的糖尿病成年人(平均年龄 68.2 [标准差,SD,9.2] 岁)。参与者符合两个标准:(1) 糖尿病诊断(曾经)和 (2) 目前使用糖尿病药物。肌肉力量采用手握式测力法进行评估(单位:千克)。在控制各种混杂因素的情况下,我们使用带限制性立方样条的时变 Cox 回归确定了肌肉力量与全因死亡率和特定原因死亡率的前瞻性关联:在平均 5.9 年(SD 3.8)的随访期间,2754 名参与者死亡(17%)。以肌肉力量中位数水平(30 千克)为参照,较低和较高的肌肉力量水平分别与较高和较低的全因死亡风险呈曲线相关。肌肉力量第 10 百分位数(17 千克)的危险比 (HR) 为 1.65(95% 置信区间 (CI) 1.53-1.79)。肌肉力量第 90 百分位数(47 千克)显示的危险比为 0.55(95% 置信区间为 0.49-0.63)。心血管疾病(CVD)、呼吸系统疾病、严重传染病、消化系统疾病和癌症导致的死亡率也呈现出某种类似的模式,但相关性强弱不一:结论:肌肉力量逐渐与糖尿病老年人的全因和特定原因死亡风险成反比。由于肌肉力量对所有年龄段的阻力训练都有很强的适应性,因此本研究结果强调了提高老年糖尿病患者肌肉力量的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetes, Obesity & Metabolism
Diabetes, Obesity & Metabolism 医学-内分泌学与代谢
CiteScore
10.90
自引率
6.90%
发文量
319
审稿时长
3-8 weeks
期刊介绍: Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信